4//SEC Filing
DEMAREE JOHN 4
Accession 0001209191-20-019703
CIK 0001503802other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 5:30 PM ET
Size
5.5 KB
Accession
0001209191-20-019703
Insider Transaction Report
Form 4
DEMAREE JOHN
Chief Commercial Officer
Transactions
- Award
Nonstatutory Stock Option (right to buy)
2020-03-16+151,200→ 151,200 totalExercise: $16.50Exp: 2030-03-15→ Common Stock (151,200 underlying)
Footnotes (1)
- [F1]This option was granted on March 16, 2020. The shares underlying this option vest as to 25% of the shares on March 16, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001744959
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 5:30 PM ET
- Size
- 5.5 KB